Global Apheresis Station Market Growth 2026-2032
The global Apheresis Station market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Apheresis stations specialize in plasma apheresis and generally have departments such as blood source management, physical examination, inspection, quality control, plasma apheresis, sterilization supply, and refrigerated transportation.
United States market for Apheresis Station is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Apheresis Station is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Apheresis Station is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Apheresis Station players cover Grifols, CSL Behring, Takeda, Octapharma, Tiantan Biological, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Apheresis Station Industry Forecast” looks at past sales and reviews total world Apheresis Station sales in 2025, providing a comprehensive analysis by region and market sector of projected Apheresis Station sales for 2026 through 2032. With Apheresis Station sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Apheresis Station industry.
This Insight Report provides a comprehensive analysis of the global Apheresis Station landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Apheresis Station portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Apheresis Station market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Apheresis Station and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Apheresis Station.
This report presents a comprehensive overview, market shares, and growth opportunities of Apheresis Station market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Apheresis Station market?
What factors are driving Apheresis Station market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Apheresis Station market opportunities vary by end market size?
How does Apheresis Station break out by Type, by Application?
Apheresis stations specialize in plasma apheresis and generally have departments such as blood source management, physical examination, inspection, quality control, plasma apheresis, sterilization supply, and refrigerated transportation.
United States market for Apheresis Station is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Apheresis Station is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Apheresis Station is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Apheresis Station players cover Grifols, CSL Behring, Takeda, Octapharma, Tiantan Biological, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Apheresis Station Industry Forecast” looks at past sales and reviews total world Apheresis Station sales in 2025, providing a comprehensive analysis by region and market sector of projected Apheresis Station sales for 2026 through 2032. With Apheresis Station sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Apheresis Station industry.
This Insight Report provides a comprehensive analysis of the global Apheresis Station landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Apheresis Station portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Apheresis Station market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Apheresis Station and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Apheresis Station.
This report presents a comprehensive overview, market shares, and growth opportunities of Apheresis Station market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Immunoglobulin
- Clotting Factor
- Others
- Immune System Disease Treatment
- Blood Coagulation Disorder Treatment
- Other Medical Applications
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Grifols
- CSL Behring
- Takeda
- Octapharma
- Tiantan Biological
- Shanghai RAAS Blood Products
- Hualan Biological Engineering
- Kedrion Biopharma
- Pacific Shuanglin Bio-pharmacy
- China Resources Boya Bio-pharmaceutical
- Shenzhen Weiguang Biological Products
- BioLife Plasma Services
- Biotest
- GC Pharma
- LFB Group
What is the 10-year outlook for the global Apheresis Station market?
What factors are driving Apheresis Station market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Apheresis Station market opportunities vary by end market size?
How does Apheresis Station break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Apheresis Station Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Apheresis Station by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Apheresis Station by Country/Region, 2021, 2025 & 2032
2.2 Apheresis Station Segment by Type
2.2.1 Immunoglobulin
2.2.2 Clotting Factor
2.2.3 Others
2.2.4 Apheresis Station Sales by Type
2.2.4.1 Global Apheresis Station Sales Market Share by Type (2021-2026)
2.2.4.2 Global Apheresis Station Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Apheresis Station Sale Price by Type (2021-2026)
2.3 Apheresis Station Segment by Application
2.3.1 Immune System Disease Treatment
2.3.2 Blood Coagulation Disorder Treatment
2.3.3 Other Medical Applications
2.3.4 Apheresis Station Sales by Application
2.3.4.1 Global Apheresis Station Sale Market Share by Application (2021-2026)
2.3.4.2 Global Apheresis Station Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Apheresis Station Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Apheresis Station Breakdown Data by Company
3.1.1 Global Apheresis Station Annual Sales by Company (2021-2026)
3.1.2 Global Apheresis Station Sales Market Share by Company (2021-2026)
3.2 Global Apheresis Station Annual Revenue by Company (2021-2026)
3.2.1 Global Apheresis Station Revenue by Company (2021-2026)
3.2.2 Global Apheresis Station Revenue Market Share by Company (2021-2026)
3.3 Global Apheresis Station Sale Price by Company
3.4 Key Manufacturers Apheresis Station Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Apheresis Station Product Location Distribution
3.4.2 Players Apheresis Station Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR APHERESIS STATION BY GEOGRAPHIC REGION
4.1 World Historic Apheresis Station Market Size by Geographic Region (2021-2026)
4.1.1 Global Apheresis Station Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Apheresis Station Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Apheresis Station Market Size by Country/Region (2021-2026)
4.2.1 Global Apheresis Station Annual Sales by Country/Region (2021-2026)
4.2.2 Global Apheresis Station Annual Revenue by Country/Region (2021-2026)
4.3 Americas Apheresis Station Sales Growth
4.4 APAC Apheresis Station Sales Growth
4.5 Europe Apheresis Station Sales Growth
4.6 Middle East & Africa Apheresis Station Sales Growth
5 AMERICAS
5.1 Americas Apheresis Station Sales by Country
5.1.1 Americas Apheresis Station Sales by Country (2021-2026)
5.1.2 Americas Apheresis Station Revenue by Country (2021-2026)
5.2 Americas Apheresis Station Sales by Type (2021-2026)
5.3 Americas Apheresis Station Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Apheresis Station Sales by Region
6.1.1 APAC Apheresis Station Sales by Region (2021-2026)
6.1.2 APAC Apheresis Station Revenue by Region (2021-2026)
6.2 APAC Apheresis Station Sales by Type (2021-2026)
6.3 APAC Apheresis Station Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Apheresis Station by Country
7.1.1 Europe Apheresis Station Sales by Country (2021-2026)
7.1.2 Europe Apheresis Station Revenue by Country (2021-2026)
7.2 Europe Apheresis Station Sales by Type (2021-2026)
7.3 Europe Apheresis Station Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Apheresis Station by Country
8.1.1 Middle East & Africa Apheresis Station Sales by Country (2021-2026)
8.1.2 Middle East & Africa Apheresis Station Revenue by Country (2021-2026)
8.2 Middle East & Africa Apheresis Station Sales by Type (2021-2026)
8.3 Middle East & Africa Apheresis Station Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Apheresis Station
10.3 Manufacturing Process Analysis of Apheresis Station
10.4 Industry Chain Structure of Apheresis Station
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Apheresis Station Distributors
11.3 Apheresis Station Customer
12 WORLD FORECAST REVIEW FOR APHERESIS STATION BY GEOGRAPHIC REGION
12.1 Global Apheresis Station Market Size Forecast by Region
12.1.1 Global Apheresis Station Forecast by Region (2027-2032)
12.1.2 Global Apheresis Station Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Apheresis Station Forecast by Type (2027-2032)
12.7 Global Apheresis Station Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Grifols
13.1.1 Grifols Company Information
13.1.2 Grifols Apheresis Station Product Portfolios and Specifications
13.1.3 Grifols Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Grifols Main Business Overview
13.1.5 Grifols Latest Developments
13.2 CSL Behring
13.2.1 CSL Behring Company Information
13.2.2 CSL Behring Apheresis Station Product Portfolios and Specifications
13.2.3 CSL Behring Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CSL Behring Main Business Overview
13.2.5 CSL Behring Latest Developments
13.3 Takeda
13.3.1 Takeda Company Information
13.3.2 Takeda Apheresis Station Product Portfolios and Specifications
13.3.3 Takeda Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Takeda Main Business Overview
13.3.5 Takeda Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Apheresis Station Product Portfolios and Specifications
13.4.3 Octapharma Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Tiantan Biological
13.5.1 Tiantan Biological Company Information
13.5.2 Tiantan Biological Apheresis Station Product Portfolios and Specifications
13.5.3 Tiantan Biological Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Tiantan Biological Main Business Overview
13.5.5 Tiantan Biological Latest Developments
13.6 Shanghai RAAS Blood Products
13.6.1 Shanghai RAAS Blood Products Company Information
13.6.2 Shanghai RAAS Blood Products Apheresis Station Product Portfolios and Specifications
13.6.3 Shanghai RAAS Blood Products Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Shanghai RAAS Blood Products Main Business Overview
13.6.5 Shanghai RAAS Blood Products Latest Developments
13.7 Hualan Biological Engineering
13.7.1 Hualan Biological Engineering Company Information
13.7.2 Hualan Biological Engineering Apheresis Station Product Portfolios and Specifications
13.7.3 Hualan Biological Engineering Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Hualan Biological Engineering Main Business Overview
13.7.5 Hualan Biological Engineering Latest Developments
13.8 Kedrion Biopharma
13.8.1 Kedrion Biopharma Company Information
13.8.2 Kedrion Biopharma Apheresis Station Product Portfolios and Specifications
13.8.3 Kedrion Biopharma Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Kedrion Biopharma Main Business Overview
13.8.5 Kedrion Biopharma Latest Developments
13.9 Pacific Shuanglin Bio-pharmacy
13.9.1 Pacific Shuanglin Bio-pharmacy Company Information
13.9.2 Pacific Shuanglin Bio-pharmacy Apheresis Station Product Portfolios and Specifications
13.9.3 Pacific Shuanglin Bio-pharmacy Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Pacific Shuanglin Bio-pharmacy Main Business Overview
13.9.5 Pacific Shuanglin Bio-pharmacy Latest Developments
13.10 China Resources Boya Bio-pharmaceutical
13.10.1 China Resources Boya Bio-pharmaceutical Company Information
13.10.2 China Resources Boya Bio-pharmaceutical Apheresis Station Product Portfolios and Specifications
13.10.3 China Resources Boya Bio-pharmaceutical Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 China Resources Boya Bio-pharmaceutical Main Business Overview
13.10.5 China Resources Boya Bio-pharmaceutical Latest Developments
13.11 Shenzhen Weiguang Biological Products
13.11.1 Shenzhen Weiguang Biological Products Company Information
13.11.2 Shenzhen Weiguang Biological Products Apheresis Station Product Portfolios and Specifications
13.11.3 Shenzhen Weiguang Biological Products Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Shenzhen Weiguang Biological Products Main Business Overview
13.11.5 Shenzhen Weiguang Biological Products Latest Developments
13.12 BioLife Plasma Services
13.12.1 BioLife Plasma Services Company Information
13.12.2 BioLife Plasma Services Apheresis Station Product Portfolios and Specifications
13.12.3 BioLife Plasma Services Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 BioLife Plasma Services Main Business Overview
13.12.5 BioLife Plasma Services Latest Developments
13.13 Biotest
13.13.1 Biotest Company Information
13.13.2 Biotest Apheresis Station Product Portfolios and Specifications
13.13.3 Biotest Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Biotest Main Business Overview
13.13.5 Biotest Latest Developments
13.14 GC Pharma
13.14.1 GC Pharma Company Information
13.14.2 GC Pharma Apheresis Station Product Portfolios and Specifications
13.14.3 GC Pharma Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 GC Pharma Main Business Overview
13.14.5 GC Pharma Latest Developments
13.15 LFB Group
13.15.1 LFB Group Company Information
13.15.2 LFB Group Apheresis Station Product Portfolios and Specifications
13.15.3 LFB Group Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 LFB Group Main Business Overview
13.15.5 LFB Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Apheresis Station Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Apheresis Station by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Apheresis Station by Country/Region, 2021, 2025 & 2032
2.2 Apheresis Station Segment by Type
2.2.1 Immunoglobulin
2.2.2 Clotting Factor
2.2.3 Others
2.2.4 Apheresis Station Sales by Type
2.2.4.1 Global Apheresis Station Sales Market Share by Type (2021-2026)
2.2.4.2 Global Apheresis Station Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Apheresis Station Sale Price by Type (2021-2026)
2.3 Apheresis Station Segment by Application
2.3.1 Immune System Disease Treatment
2.3.2 Blood Coagulation Disorder Treatment
2.3.3 Other Medical Applications
2.3.4 Apheresis Station Sales by Application
2.3.4.1 Global Apheresis Station Sale Market Share by Application (2021-2026)
2.3.4.2 Global Apheresis Station Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Apheresis Station Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Apheresis Station Breakdown Data by Company
3.1.1 Global Apheresis Station Annual Sales by Company (2021-2026)
3.1.2 Global Apheresis Station Sales Market Share by Company (2021-2026)
3.2 Global Apheresis Station Annual Revenue by Company (2021-2026)
3.2.1 Global Apheresis Station Revenue by Company (2021-2026)
3.2.2 Global Apheresis Station Revenue Market Share by Company (2021-2026)
3.3 Global Apheresis Station Sale Price by Company
3.4 Key Manufacturers Apheresis Station Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Apheresis Station Product Location Distribution
3.4.2 Players Apheresis Station Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR APHERESIS STATION BY GEOGRAPHIC REGION
4.1 World Historic Apheresis Station Market Size by Geographic Region (2021-2026)
4.1.1 Global Apheresis Station Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Apheresis Station Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Apheresis Station Market Size by Country/Region (2021-2026)
4.2.1 Global Apheresis Station Annual Sales by Country/Region (2021-2026)
4.2.2 Global Apheresis Station Annual Revenue by Country/Region (2021-2026)
4.3 Americas Apheresis Station Sales Growth
4.4 APAC Apheresis Station Sales Growth
4.5 Europe Apheresis Station Sales Growth
4.6 Middle East & Africa Apheresis Station Sales Growth
5 AMERICAS
5.1 Americas Apheresis Station Sales by Country
5.1.1 Americas Apheresis Station Sales by Country (2021-2026)
5.1.2 Americas Apheresis Station Revenue by Country (2021-2026)
5.2 Americas Apheresis Station Sales by Type (2021-2026)
5.3 Americas Apheresis Station Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Apheresis Station Sales by Region
6.1.1 APAC Apheresis Station Sales by Region (2021-2026)
6.1.2 APAC Apheresis Station Revenue by Region (2021-2026)
6.2 APAC Apheresis Station Sales by Type (2021-2026)
6.3 APAC Apheresis Station Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Apheresis Station by Country
7.1.1 Europe Apheresis Station Sales by Country (2021-2026)
7.1.2 Europe Apheresis Station Revenue by Country (2021-2026)
7.2 Europe Apheresis Station Sales by Type (2021-2026)
7.3 Europe Apheresis Station Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Apheresis Station by Country
8.1.1 Middle East & Africa Apheresis Station Sales by Country (2021-2026)
8.1.2 Middle East & Africa Apheresis Station Revenue by Country (2021-2026)
8.2 Middle East & Africa Apheresis Station Sales by Type (2021-2026)
8.3 Middle East & Africa Apheresis Station Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Apheresis Station
10.3 Manufacturing Process Analysis of Apheresis Station
10.4 Industry Chain Structure of Apheresis Station
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Apheresis Station Distributors
11.3 Apheresis Station Customer
12 WORLD FORECAST REVIEW FOR APHERESIS STATION BY GEOGRAPHIC REGION
12.1 Global Apheresis Station Market Size Forecast by Region
12.1.1 Global Apheresis Station Forecast by Region (2027-2032)
12.1.2 Global Apheresis Station Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Apheresis Station Forecast by Type (2027-2032)
12.7 Global Apheresis Station Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Grifols
13.1.1 Grifols Company Information
13.1.2 Grifols Apheresis Station Product Portfolios and Specifications
13.1.3 Grifols Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Grifols Main Business Overview
13.1.5 Grifols Latest Developments
13.2 CSL Behring
13.2.1 CSL Behring Company Information
13.2.2 CSL Behring Apheresis Station Product Portfolios and Specifications
13.2.3 CSL Behring Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CSL Behring Main Business Overview
13.2.5 CSL Behring Latest Developments
13.3 Takeda
13.3.1 Takeda Company Information
13.3.2 Takeda Apheresis Station Product Portfolios and Specifications
13.3.3 Takeda Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Takeda Main Business Overview
13.3.5 Takeda Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Apheresis Station Product Portfolios and Specifications
13.4.3 Octapharma Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Tiantan Biological
13.5.1 Tiantan Biological Company Information
13.5.2 Tiantan Biological Apheresis Station Product Portfolios and Specifications
13.5.3 Tiantan Biological Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Tiantan Biological Main Business Overview
13.5.5 Tiantan Biological Latest Developments
13.6 Shanghai RAAS Blood Products
13.6.1 Shanghai RAAS Blood Products Company Information
13.6.2 Shanghai RAAS Blood Products Apheresis Station Product Portfolios and Specifications
13.6.3 Shanghai RAAS Blood Products Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Shanghai RAAS Blood Products Main Business Overview
13.6.5 Shanghai RAAS Blood Products Latest Developments
13.7 Hualan Biological Engineering
13.7.1 Hualan Biological Engineering Company Information
13.7.2 Hualan Biological Engineering Apheresis Station Product Portfolios and Specifications
13.7.3 Hualan Biological Engineering Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Hualan Biological Engineering Main Business Overview
13.7.5 Hualan Biological Engineering Latest Developments
13.8 Kedrion Biopharma
13.8.1 Kedrion Biopharma Company Information
13.8.2 Kedrion Biopharma Apheresis Station Product Portfolios and Specifications
13.8.3 Kedrion Biopharma Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Kedrion Biopharma Main Business Overview
13.8.5 Kedrion Biopharma Latest Developments
13.9 Pacific Shuanglin Bio-pharmacy
13.9.1 Pacific Shuanglin Bio-pharmacy Company Information
13.9.2 Pacific Shuanglin Bio-pharmacy Apheresis Station Product Portfolios and Specifications
13.9.3 Pacific Shuanglin Bio-pharmacy Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Pacific Shuanglin Bio-pharmacy Main Business Overview
13.9.5 Pacific Shuanglin Bio-pharmacy Latest Developments
13.10 China Resources Boya Bio-pharmaceutical
13.10.1 China Resources Boya Bio-pharmaceutical Company Information
13.10.2 China Resources Boya Bio-pharmaceutical Apheresis Station Product Portfolios and Specifications
13.10.3 China Resources Boya Bio-pharmaceutical Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 China Resources Boya Bio-pharmaceutical Main Business Overview
13.10.5 China Resources Boya Bio-pharmaceutical Latest Developments
13.11 Shenzhen Weiguang Biological Products
13.11.1 Shenzhen Weiguang Biological Products Company Information
13.11.2 Shenzhen Weiguang Biological Products Apheresis Station Product Portfolios and Specifications
13.11.3 Shenzhen Weiguang Biological Products Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Shenzhen Weiguang Biological Products Main Business Overview
13.11.5 Shenzhen Weiguang Biological Products Latest Developments
13.12 BioLife Plasma Services
13.12.1 BioLife Plasma Services Company Information
13.12.2 BioLife Plasma Services Apheresis Station Product Portfolios and Specifications
13.12.3 BioLife Plasma Services Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 BioLife Plasma Services Main Business Overview
13.12.5 BioLife Plasma Services Latest Developments
13.13 Biotest
13.13.1 Biotest Company Information
13.13.2 Biotest Apheresis Station Product Portfolios and Specifications
13.13.3 Biotest Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Biotest Main Business Overview
13.13.5 Biotest Latest Developments
13.14 GC Pharma
13.14.1 GC Pharma Company Information
13.14.2 GC Pharma Apheresis Station Product Portfolios and Specifications
13.14.3 GC Pharma Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 GC Pharma Main Business Overview
13.14.5 GC Pharma Latest Developments
13.15 LFB Group
13.15.1 LFB Group Company Information
13.15.2 LFB Group Apheresis Station Product Portfolios and Specifications
13.15.3 LFB Group Apheresis Station Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 LFB Group Main Business Overview
13.15.5 LFB Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Apheresis Station Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Apheresis Station Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Immunoglobulin
Table 4. Major Players of Clotting Factor
Table 5. Major Players of Others
Table 6. Global Apheresis Station Sales by Type (2021-2026) & (K Units)
Table 7. Global Apheresis Station Sales Market Share by Type (2021-2026)
Table 8. Global Apheresis Station Revenue by Type (2021-2026) & ($ million)
Table 9. Global Apheresis Station Revenue Market Share by Type (2021-2026)
Table 10. Global Apheresis Station Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Apheresis Station Sale by Application (2021-2026) & (K Units)
Table 12. Global Apheresis Station Sale Market Share by Application (2021-2026)
Table 13. Global Apheresis Station Revenue by Application (2021-2026) & ($ million)
Table 14. Global Apheresis Station Revenue Market Share by Application (2021-2026)
Table 15. Global Apheresis Station Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Apheresis Station Sales by Company (2021-2026) & (K Units)
Table 17. Global Apheresis Station Sales Market Share by Company (2021-2026)
Table 18. Global Apheresis Station Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Apheresis Station Revenue Market Share by Company (2021-2026)
Table 20. Global Apheresis Station Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Apheresis Station Producing Area Distribution and Sales Area
Table 22. Players Apheresis Station Products Offered
Table 23. Apheresis Station Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Apheresis Station Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Apheresis Station Sales Market Share Geographic Region (2021-2026)
Table 28. Global Apheresis Station Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Apheresis Station Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Apheresis Station Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Apheresis Station Sales Market Share by Country/Region (2021-2026)
Table 32. Global Apheresis Station Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Apheresis Station Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Apheresis Station Sales by Country (2021-2026) & (K Units)
Table 35. Americas Apheresis Station Sales Market Share by Country (2021-2026)
Table 36. Americas Apheresis Station Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Apheresis Station Sales by Type (2021-2026) & (K Units)
Table 38. Americas Apheresis Station Sales by Application (2021-2026) & (K Units)
Table 39. APAC Apheresis Station Sales by Region (2021-2026) & (K Units)
Table 40. APAC Apheresis Station Sales Market Share by Region (2021-2026)
Table 41. APAC Apheresis Station Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Apheresis Station Sales by Type (2021-2026) & (K Units)
Table 43. APAC Apheresis Station Sales by Application (2021-2026) & (K Units)
Table 44. Europe Apheresis Station Sales by Country (2021-2026) & (K Units)
Table 45. Europe Apheresis Station Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Apheresis Station Sales by Type (2021-2026) & (K Units)
Table 47. Europe Apheresis Station Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Apheresis Station Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Apheresis Station Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Apheresis Station Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Apheresis Station Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Apheresis Station
Table 53. Key Market Challenges & Risks of Apheresis Station
Table 54. Key Industry Trends of Apheresis Station
Table 55. Apheresis Station Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Apheresis Station Distributors List
Table 58. Apheresis Station Customer List
Table 59. Global Apheresis Station Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Apheresis Station Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Apheresis Station Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Apheresis Station Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Apheresis Station Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Apheresis Station Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Apheresis Station Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Apheresis Station Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Apheresis Station Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Apheresis Station Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Apheresis Station Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Apheresis Station Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Apheresis Station Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Apheresis Station Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Grifols Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 74. Grifols Apheresis Station Product Portfolios and Specifications
Table 75. Grifols Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Grifols Main Business
Table 77. Grifols Latest Developments
Table 78. CSL Behring Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 79. CSL Behring Apheresis Station Product Portfolios and Specifications
Table 80. CSL Behring Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. CSL Behring Main Business
Table 82. CSL Behring Latest Developments
Table 83. Takeda Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 84. Takeda Apheresis Station Product Portfolios and Specifications
Table 85. Takeda Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Takeda Main Business
Table 87. Takeda Latest Developments
Table 88. Octapharma Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 89. Octapharma Apheresis Station Product Portfolios and Specifications
Table 90. Octapharma Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Octapharma Main Business
Table 92. Octapharma Latest Developments
Table 93. Tiantan Biological Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 94. Tiantan Biological Apheresis Station Product Portfolios and Specifications
Table 95. Tiantan Biological Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Tiantan Biological Main Business
Table 97. Tiantan Biological Latest Developments
Table 98. Shanghai RAAS Blood Products Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 99. Shanghai RAAS Blood Products Apheresis Station Product Portfolios and Specifications
Table 100. Shanghai RAAS Blood Products Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Shanghai RAAS Blood Products Main Business
Table 102. Shanghai RAAS Blood Products Latest Developments
Table 103. Hualan Biological Engineering Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 104. Hualan Biological Engineering Apheresis Station Product Portfolios and Specifications
Table 105. Hualan Biological Engineering Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Hualan Biological Engineering Main Business
Table 107. Hualan Biological Engineering Latest Developments
Table 108. Kedrion Biopharma Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 109. Kedrion Biopharma Apheresis Station Product Portfolios and Specifications
Table 110. Kedrion Biopharma Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Kedrion Biopharma Main Business
Table 112. Kedrion Biopharma Latest Developments
Table 113. Pacific Shuanglin Bio-pharmacy Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 114. Pacific Shuanglin Bio-pharmacy Apheresis Station Product Portfolios and Specifications
Table 115. Pacific Shuanglin Bio-pharmacy Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Pacific Shuanglin Bio-pharmacy Main Business
Table 117. Pacific Shuanglin Bio-pharmacy Latest Developments
Table 118. China Resources Boya Bio-pharmaceutical Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 119. China Resources Boya Bio-pharmaceutical Apheresis Station Product Portfolios and Specifications
Table 120. China Resources Boya Bio-pharmaceutical Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. China Resources Boya Bio-pharmaceutical Main Business
Table 122. China Resources Boya Bio-pharmaceutical Latest Developments
Table 123. Shenzhen Weiguang Biological Products Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 124. Shenzhen Weiguang Biological Products Apheresis Station Product Portfolios and Specifications
Table 125. Shenzhen Weiguang Biological Products Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Shenzhen Weiguang Biological Products Main Business
Table 127. Shenzhen Weiguang Biological Products Latest Developments
Table 128. BioLife Plasma Services Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 129. BioLife Plasma Services Apheresis Station Product Portfolios and Specifications
Table 130. BioLife Plasma Services Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. BioLife Plasma Services Main Business
Table 132. BioLife Plasma Services Latest Developments
Table 133. Biotest Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 134. Biotest Apheresis Station Product Portfolios and Specifications
Table 135. Biotest Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Biotest Main Business
Table 137. Biotest Latest Developments
Table 138. GC Pharma Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 139. GC Pharma Apheresis Station Product Portfolios and Specifications
Table 140. GC Pharma Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. GC Pharma Main Business
Table 142. GC Pharma Latest Developments
Table 143. LFB Group Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 144. LFB Group Apheresis Station Product Portfolios and Specifications
Table 145. LFB Group Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. LFB Group Main Business
Table 147. LFB Group Latest Developments
Table 1. Apheresis Station Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Apheresis Station Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Immunoglobulin
Table 4. Major Players of Clotting Factor
Table 5. Major Players of Others
Table 6. Global Apheresis Station Sales by Type (2021-2026) & (K Units)
Table 7. Global Apheresis Station Sales Market Share by Type (2021-2026)
Table 8. Global Apheresis Station Revenue by Type (2021-2026) & ($ million)
Table 9. Global Apheresis Station Revenue Market Share by Type (2021-2026)
Table 10. Global Apheresis Station Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Apheresis Station Sale by Application (2021-2026) & (K Units)
Table 12. Global Apheresis Station Sale Market Share by Application (2021-2026)
Table 13. Global Apheresis Station Revenue by Application (2021-2026) & ($ million)
Table 14. Global Apheresis Station Revenue Market Share by Application (2021-2026)
Table 15. Global Apheresis Station Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Apheresis Station Sales by Company (2021-2026) & (K Units)
Table 17. Global Apheresis Station Sales Market Share by Company (2021-2026)
Table 18. Global Apheresis Station Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Apheresis Station Revenue Market Share by Company (2021-2026)
Table 20. Global Apheresis Station Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Apheresis Station Producing Area Distribution and Sales Area
Table 22. Players Apheresis Station Products Offered
Table 23. Apheresis Station Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Apheresis Station Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Apheresis Station Sales Market Share Geographic Region (2021-2026)
Table 28. Global Apheresis Station Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Apheresis Station Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Apheresis Station Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Apheresis Station Sales Market Share by Country/Region (2021-2026)
Table 32. Global Apheresis Station Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Apheresis Station Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Apheresis Station Sales by Country (2021-2026) & (K Units)
Table 35. Americas Apheresis Station Sales Market Share by Country (2021-2026)
Table 36. Americas Apheresis Station Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Apheresis Station Sales by Type (2021-2026) & (K Units)
Table 38. Americas Apheresis Station Sales by Application (2021-2026) & (K Units)
Table 39. APAC Apheresis Station Sales by Region (2021-2026) & (K Units)
Table 40. APAC Apheresis Station Sales Market Share by Region (2021-2026)
Table 41. APAC Apheresis Station Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Apheresis Station Sales by Type (2021-2026) & (K Units)
Table 43. APAC Apheresis Station Sales by Application (2021-2026) & (K Units)
Table 44. Europe Apheresis Station Sales by Country (2021-2026) & (K Units)
Table 45. Europe Apheresis Station Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Apheresis Station Sales by Type (2021-2026) & (K Units)
Table 47. Europe Apheresis Station Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Apheresis Station Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Apheresis Station Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Apheresis Station Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Apheresis Station Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Apheresis Station
Table 53. Key Market Challenges & Risks of Apheresis Station
Table 54. Key Industry Trends of Apheresis Station
Table 55. Apheresis Station Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Apheresis Station Distributors List
Table 58. Apheresis Station Customer List
Table 59. Global Apheresis Station Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Apheresis Station Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Apheresis Station Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Apheresis Station Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Apheresis Station Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Apheresis Station Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Apheresis Station Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Apheresis Station Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Apheresis Station Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Apheresis Station Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Apheresis Station Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Apheresis Station Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Apheresis Station Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Apheresis Station Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Grifols Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 74. Grifols Apheresis Station Product Portfolios and Specifications
Table 75. Grifols Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Grifols Main Business
Table 77. Grifols Latest Developments
Table 78. CSL Behring Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 79. CSL Behring Apheresis Station Product Portfolios and Specifications
Table 80. CSL Behring Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. CSL Behring Main Business
Table 82. CSL Behring Latest Developments
Table 83. Takeda Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 84. Takeda Apheresis Station Product Portfolios and Specifications
Table 85. Takeda Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Takeda Main Business
Table 87. Takeda Latest Developments
Table 88. Octapharma Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 89. Octapharma Apheresis Station Product Portfolios and Specifications
Table 90. Octapharma Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Octapharma Main Business
Table 92. Octapharma Latest Developments
Table 93. Tiantan Biological Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 94. Tiantan Biological Apheresis Station Product Portfolios and Specifications
Table 95. Tiantan Biological Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Tiantan Biological Main Business
Table 97. Tiantan Biological Latest Developments
Table 98. Shanghai RAAS Blood Products Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 99. Shanghai RAAS Blood Products Apheresis Station Product Portfolios and Specifications
Table 100. Shanghai RAAS Blood Products Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Shanghai RAAS Blood Products Main Business
Table 102. Shanghai RAAS Blood Products Latest Developments
Table 103. Hualan Biological Engineering Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 104. Hualan Biological Engineering Apheresis Station Product Portfolios and Specifications
Table 105. Hualan Biological Engineering Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Hualan Biological Engineering Main Business
Table 107. Hualan Biological Engineering Latest Developments
Table 108. Kedrion Biopharma Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 109. Kedrion Biopharma Apheresis Station Product Portfolios and Specifications
Table 110. Kedrion Biopharma Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Kedrion Biopharma Main Business
Table 112. Kedrion Biopharma Latest Developments
Table 113. Pacific Shuanglin Bio-pharmacy Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 114. Pacific Shuanglin Bio-pharmacy Apheresis Station Product Portfolios and Specifications
Table 115. Pacific Shuanglin Bio-pharmacy Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Pacific Shuanglin Bio-pharmacy Main Business
Table 117. Pacific Shuanglin Bio-pharmacy Latest Developments
Table 118. China Resources Boya Bio-pharmaceutical Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 119. China Resources Boya Bio-pharmaceutical Apheresis Station Product Portfolios and Specifications
Table 120. China Resources Boya Bio-pharmaceutical Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. China Resources Boya Bio-pharmaceutical Main Business
Table 122. China Resources Boya Bio-pharmaceutical Latest Developments
Table 123. Shenzhen Weiguang Biological Products Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 124. Shenzhen Weiguang Biological Products Apheresis Station Product Portfolios and Specifications
Table 125. Shenzhen Weiguang Biological Products Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Shenzhen Weiguang Biological Products Main Business
Table 127. Shenzhen Weiguang Biological Products Latest Developments
Table 128. BioLife Plasma Services Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 129. BioLife Plasma Services Apheresis Station Product Portfolios and Specifications
Table 130. BioLife Plasma Services Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. BioLife Plasma Services Main Business
Table 132. BioLife Plasma Services Latest Developments
Table 133. Biotest Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 134. Biotest Apheresis Station Product Portfolios and Specifications
Table 135. Biotest Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Biotest Main Business
Table 137. Biotest Latest Developments
Table 138. GC Pharma Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 139. GC Pharma Apheresis Station Product Portfolios and Specifications
Table 140. GC Pharma Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. GC Pharma Main Business
Table 142. GC Pharma Latest Developments
Table 143. LFB Group Basic Information, Apheresis Station Manufacturing Base, Sales Area and Its Competitors
Table 144. LFB Group Apheresis Station Product Portfolios and Specifications
Table 145. LFB Group Apheresis Station Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. LFB Group Main Business
Table 147. LFB Group Latest Developments
LIST OF FIGURES
Figure 1. Picture of Apheresis Station
Figure 2. Apheresis Station Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Apheresis Station Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Apheresis Station Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Apheresis Station Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Apheresis Station Sales Market Share by Country/Region (2025)
Figure 10. Apheresis Station Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Immunoglobulin
Figure 12. Product Picture of Clotting Factor
Figure 13. Product Picture of Others
Figure 14. Global Apheresis Station Sales Market Share by Type in 2026
Figure 15. Global Apheresis Station Revenue Market Share by Type (2021-2026)
Figure 16. Apheresis Station Consumed in Immune System Disease Treatment
Figure 17. Global Apheresis Station Market: Immune System Disease Treatment (2021-2026) & (K Units)
Figure 18. Apheresis Station Consumed in Blood Coagulation Disorder Treatment
Figure 19. Global Apheresis Station Market: Blood Coagulation Disorder Treatment (2021-2026) & (K Units)
Figure 20. Apheresis Station Consumed in Other Medical Applications
Figure 21. Global Apheresis Station Market: Other Medical Applications (2021-2026) & (K Units)
Figure 22. Global Apheresis Station Sale Market Share by Application (2025)
Figure 23. Global Apheresis Station Revenue Market Share by Application in 2026
Figure 24. Apheresis Station Sales by Company in 2026 (K Units)
Figure 25. Global Apheresis Station Sales Market Share by Company in 2026
Figure 26. Apheresis Station Revenue by Company in 2026 ($ millions)
Figure 27. Global Apheresis Station Revenue Market Share by Company in 2026
Figure 28. Global Apheresis Station Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Apheresis Station Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Apheresis Station Sales 2021-2026 (K Units)
Figure 31. Americas Apheresis Station Revenue 2021-2026 ($ millions)
Figure 32. APAC Apheresis Station Sales 2021-2026 (K Units)
Figure 33. APAC Apheresis Station Revenue 2021-2026 ($ millions)
Figure 34. Europe Apheresis Station Sales 2021-2026 (K Units)
Figure 35. Europe Apheresis Station Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Apheresis Station Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Apheresis Station Revenue 2021-2026 ($ millions)
Figure 38. Americas Apheresis Station Sales Market Share by Country in 2026
Figure 39. Americas Apheresis Station Revenue Market Share by Country (2021-2026)
Figure 40. Americas Apheresis Station Sales Market Share by Type (2021-2026)
Figure 41. Americas Apheresis Station Sales Market Share by Application (2021-2026)
Figure 42. United States Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Apheresis Station Sales Market Share by Region in 2026
Figure 47. APAC Apheresis Station Revenue Market Share by Region (2021-2026)
Figure 48. APAC Apheresis Station Sales Market Share by Type (2021-2026)
Figure 49. APAC Apheresis Station Sales Market Share by Application (2021-2026)
Figure 50. China Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 54. India Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Apheresis Station Sales Market Share by Country in 2026
Figure 58. Europe Apheresis Station Revenue Market Share by Country (2021-2026)
Figure 59. Europe Apheresis Station Sales Market Share by Type (2021-2026)
Figure 60. Europe Apheresis Station Sales Market Share by Application (2021-2026)
Figure 61. Germany Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 62. France Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Apheresis Station Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Apheresis Station Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Apheresis Station Sales Market Share by Application (2021-2026)
Figure 69. Egypt Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Apheresis Station in 2026
Figure 75. Manufacturing Process Analysis of Apheresis Station
Figure 76. Industry Chain Structure of Apheresis Station
Figure 77. Channels of Distribution
Figure 78. Global Apheresis Station Sales Market Forecast by Region (2027-2032)
Figure 79. Global Apheresis Station Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Apheresis Station Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Apheresis Station Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Apheresis Station Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Apheresis Station Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Apheresis Station
Figure 2. Apheresis Station Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Apheresis Station Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Apheresis Station Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Apheresis Station Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Apheresis Station Sales Market Share by Country/Region (2025)
Figure 10. Apheresis Station Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Immunoglobulin
Figure 12. Product Picture of Clotting Factor
Figure 13. Product Picture of Others
Figure 14. Global Apheresis Station Sales Market Share by Type in 2026
Figure 15. Global Apheresis Station Revenue Market Share by Type (2021-2026)
Figure 16. Apheresis Station Consumed in Immune System Disease Treatment
Figure 17. Global Apheresis Station Market: Immune System Disease Treatment (2021-2026) & (K Units)
Figure 18. Apheresis Station Consumed in Blood Coagulation Disorder Treatment
Figure 19. Global Apheresis Station Market: Blood Coagulation Disorder Treatment (2021-2026) & (K Units)
Figure 20. Apheresis Station Consumed in Other Medical Applications
Figure 21. Global Apheresis Station Market: Other Medical Applications (2021-2026) & (K Units)
Figure 22. Global Apheresis Station Sale Market Share by Application (2025)
Figure 23. Global Apheresis Station Revenue Market Share by Application in 2026
Figure 24. Apheresis Station Sales by Company in 2026 (K Units)
Figure 25. Global Apheresis Station Sales Market Share by Company in 2026
Figure 26. Apheresis Station Revenue by Company in 2026 ($ millions)
Figure 27. Global Apheresis Station Revenue Market Share by Company in 2026
Figure 28. Global Apheresis Station Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Apheresis Station Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Apheresis Station Sales 2021-2026 (K Units)
Figure 31. Americas Apheresis Station Revenue 2021-2026 ($ millions)
Figure 32. APAC Apheresis Station Sales 2021-2026 (K Units)
Figure 33. APAC Apheresis Station Revenue 2021-2026 ($ millions)
Figure 34. Europe Apheresis Station Sales 2021-2026 (K Units)
Figure 35. Europe Apheresis Station Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Apheresis Station Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Apheresis Station Revenue 2021-2026 ($ millions)
Figure 38. Americas Apheresis Station Sales Market Share by Country in 2026
Figure 39. Americas Apheresis Station Revenue Market Share by Country (2021-2026)
Figure 40. Americas Apheresis Station Sales Market Share by Type (2021-2026)
Figure 41. Americas Apheresis Station Sales Market Share by Application (2021-2026)
Figure 42. United States Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Apheresis Station Sales Market Share by Region in 2026
Figure 47. APAC Apheresis Station Revenue Market Share by Region (2021-2026)
Figure 48. APAC Apheresis Station Sales Market Share by Type (2021-2026)
Figure 49. APAC Apheresis Station Sales Market Share by Application (2021-2026)
Figure 50. China Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 54. India Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Apheresis Station Sales Market Share by Country in 2026
Figure 58. Europe Apheresis Station Revenue Market Share by Country (2021-2026)
Figure 59. Europe Apheresis Station Sales Market Share by Type (2021-2026)
Figure 60. Europe Apheresis Station Sales Market Share by Application (2021-2026)
Figure 61. Germany Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 62. France Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Apheresis Station Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Apheresis Station Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Apheresis Station Sales Market Share by Application (2021-2026)
Figure 69. Egypt Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Apheresis Station Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Apheresis Station in 2026
Figure 75. Manufacturing Process Analysis of Apheresis Station
Figure 76. Industry Chain Structure of Apheresis Station
Figure 77. Channels of Distribution
Figure 78. Global Apheresis Station Sales Market Forecast by Region (2027-2032)
Figure 79. Global Apheresis Station Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Apheresis Station Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Apheresis Station Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Apheresis Station Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Apheresis Station Revenue Market Share Forecast by Application (2027-2032)
